Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists like Ozempic have transformed weight loss treatment, but they are not appropriate for every patient. Understanding when to avoid these medications—and knowing what safe alternatives exist—is essential for making informed health decisions. PlexusDx specializes in personalized GLP-1 therapy and genetic testing to ensure the right treatment for your unique biology.

Medical Conditions That Contraindicate GLP-1 Therapy

Certain serious health conditions make GLP-1 medications unsafe, regardless of weight loss benefits. Patients with a personal or family history of medullary thyroid carcinoma (MTC) should never use these drugs because animal studies showed dose-dependent thyroid tumors in rodents—a risk that cannot be fully ruled out in humans. Similarly, patients with multiple endocrine neoplasia syndrome type 2 (MEN2) carry inherited genetic mutations that increase thyroid cancer risk and make GLP-1 use contraindicated.

Severe pancreatitis history, active gallbladder disease, and diabetic retinopathy complications require careful evaluation before starting GLP-1 therapy. Patients with acute kidney injury or severe renal impairment (eGFR <15 mL/min) may experience dehydration-related complications. Anyone with a history of suicidal ideation or severe depression should discuss GLP-1 use with their mental health provider, as medications affecting appetite and mood require baseline psychiatric assessment.

Pregnancy, Fertility Planning, and GLP-1 Safety

Women who are pregnant or breastfeeding must discontinue GLP-1 medications because animal reproduction studies showed fetal toxicity in rodents, and no adequate human pregnancy data exists. The FDA classifies semaglutide as Pregnancy Category X equivalent, meaning the risks clearly outweigh any potential benefit. Patients planning pregnancy within six months should discuss timing and transition strategies with their healthcare provider before starting therapy.

Men and women both considering fertility should know that GLP-1 medications may need to be paused during conception attempts, depending on individual circumstances. PlexusDx encourages comprehensive discussions with reproductive endocrinologists or OB/GYN providers before beginning treatment if family planning is anticipated within the next year.

Medication Interactions and Contraindications

GLP-1 drugs slow gastric emptying, which can reduce the absorption of oral medications taken simultaneously—including birth control pills, certain antibiotics, and some blood pressure medications. Patients taking insulin or insulin-secreting medications like sulfonylureas face increased hypoglycemia risk when combined with GLP-1 therapy, requiring careful dose adjustment and blood sugar monitoring. Medications for heart failure, kidney disease, or thyroid conditions may have altered efficacy or safety profiles when used alongside GLP-1 agonists.

Anyone taking monoamine oxidase inhibitors (MAOIs), certain antidepressants, or other centrally acting drugs should have their medication list reviewed by a pharmacist before starting GLP-1 therapy. PlexusDx recommends a complete medication reconciliation appointment to identify potential interactions and ensure safe co-administration.

Personalized Alternatives: Why Genetic Testing Matters

Not every patient with obesity or metabolic syndrome requires GLP-1 therapy, and not every person responds equally to semaglutide or tirzepatide. The PlexusDx Precision Peptide Genetic Test identifies your peptide-pathway genetics across 14 metabolic pathways and 49 peptides—revealing whether you carry genetic variants in GLP1R, GIPR, FTO, or MC4R that influence drug response and side effect tolerance. Patients with certain genetic profiles may benefit more from lower-dose microdose protocols, oral formulations, or dual-compound approaches like GLP-Squared.

PlexusDx serves all 50 states with no insurance required and offers the Microdose GLP-1 Protocol ($129/mo flat) for patients who need a gentler starting point, plus Compounded Semaglutide Injection ($149/mo), Oral Semaglutide ($249/mo), and other options from licensed 503A compounding pharmacies. Genetic testing ($99 add-on after first month) helps eliminate guesswork and ensures your treatment aligns with your biology, not just your BMI.

How to Know If GLP-1 Therapy Is Right for You

The decision to start GLP-1 therapy should be based on a thorough medical history, current medication review, and assessment of weight loss goals. Ideal candidates have BMI ≥27 with weight-related complications (hypertension, type 2 diabetes, sleep apnea) or BMI ≥30 regardless of comorbidities, and no contraindications listed above. A structured intake process—including screening for thyroid cancer risk, gallbladder disease, pancreatitis, and psychiatric history—protects patient safety.

PlexusDx guides patients through evidence-based qualification criteria and offers transparent pricing: your dose may need to go up, but your price won't. Whether you qualify for standard semaglutide, explore tirzepatide, or discover that a microdose approach suits your genetics better, personalized medicine means treatment matched to you—not one-size-fits-all protocols.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

I have a family history of thyroid cancer. Can I still use Ozempic or semaglutide?

No. If you or a close relative have a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2), GLP-1 medications are absolutely contraindicated due to animal data showing thyroid tumor risk. PlexusDx screens for this during intake and can discuss safer alternatives tailored to your genetics and health profile.

What happens if I become pregnant while taking a GLP-1 medication?

You should stop immediately and contact your healthcare provider. Animal reproduction studies showed fetal toxicity, and no human pregnancy safety data exist for semaglutide or tirzepatide. PlexusDx recommends discussing fertility plans before starting therapy and pausing treatment if conception is attempted.

Does PlexusDx offer GLP-1 medications if I'm not a good candidate for standard doses?

Yes. PlexusDx offers the Microdose GLP-1 Protocol ($129/mo flat), oral formulations, and personalized dosing strategies for patients who need gentler approaches. The Precision Peptide Genetic Test identifies your peptide-pathway genetics to optimize which medication and dose strategy work best for your biology.

Can GLP-1 therapy cause pancreatitis or make gallbladder disease worse?

GLP-1 medications slow gastric emptying and can increase gallstone risk in susceptible patients; acute pancreatitis is a rare but serious side effect. Anyone with a history of pancreatitis, active gallstones, or severe biliary disease should avoid these drugs or only use them under close medical supervision with frequent monitoring.

How does the PlexusDx genetic test help if I'm not a candidate for standard GLP-1 therapy?

The Precision Peptide Genetic Test ($99 add-on) maps 14 pathways and 150+ insights into your metabolism, revealing genetic variants in GLP1R, GIPR, FTO, and MC4R. If standard GLP-1 therapy is contraindicated, the test can guide alternative peptide-based approaches, nutritional strategies, or inform discussions with your doctor about safe options aligned with your genetic profile.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves